Comments
German chemicals and pharmaceuticals giant Bayer said today that its takeover offer for US birth-control maker Conceptus has been successful.
Bayer said in a statement that Conceptus shareholders had accepted its offer of $31.00 per share and sold 31.98 million shares — or 96.4 per cent of the outstanding share capital.
“We are pleased with Conceptus stockholders’ positive response to our offer,” said Bayer chief executive Marijn Dekker.
California-based Conceptus developed the Essure procedure, a non-surgical permanent birth control method.
The German group had announced at the end of April that it has agreed to buy Conceptus for $1.1 billion.
It said it would exercise its “top-up” option whereby Conceptus will issue a number of shares to Bayer, “enabling it to gain full ownership of Conceptus without convening a general meeting of Conceptus stockholders.”
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.